Doctor profile · Federal record
Dr. Cassandra Digby, NP
Nurse Practitioner · Fort Payne, AL
- NPI 1164817607
- MIPS 85.2 / 100 · 2023
- 12 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
212 Airport RD W
Fort Payne, AL 359683347
(256) 979-1250
fax (256) 979-1251
Credentials & registration
- NPI registered
- April 2015 — 11 yrs on file
- Profile last updated
- March 5, 2026
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- Alabama #1-125202
- Medicaid
- AL #238202
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164817607. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,550
Distinct HCPCS
10
Medicare allowed
$88,403
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,205 | 215 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 347 | 298 | $71 | |
17000 |
Destruction of precancer skin growth, 1 growth | 309 | 272 | $42 | |
11102 |
Biopsy of related skin growth, first growth | 170 | 155 | $77 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 139 | 125 | $44 | |
11103 |
Biopsy of related skin growth, each additional growth | 128 | 78 | $39 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 58 | 49 | $128 | |
11104 |
Punch biopsy, first skin growth | 43 | 43 | $97 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 42 | 42 | $87 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 28 | 18 | $1 |
In context: peer comparison
Among 5 peers in Fort Payne Nurse Practitioner, average services per provider: 183. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$967
Transactions
57
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 25 | $224.46 | |
| Janssen Biotech, INC. | 5 | $158.01 | |
| Abbvie INC. | 5 | $94.94 | |
| Regeneron Healthcare Solutions, INC. | 4 | $94.45 | |
| Genzyme Corporation | 2 | $65.27 | |
| Novartis Pharmaceuticals Corporation | 3 | $61.67 | |
| Amgen INC. | 3 | $54.77 | |
| Sun Pharmaceutical Industries INC. | 2 | $43.90 | |
| Lilly USA, LLC | 2 | $39.93 | |
| Boston Scientific Corporation | 1 | $34.65 | |
| Ucb, INC. | 1 | $32.96 | |
| Mimedx Group, INC. | 2 | $29.59 | |
| Arcutis Biotherapeutics, INC. | 1 | $23.60 | |
| Mayne Pharma Commercial LLC | 1 | $8.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
760
Patients
346
Total drug cost
$359,713
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 123 | 70 | $7,557 |
| Triamcinolone Acetonide | Generic | 119 | 91 | $2,082 |
| Ketoconazole | Generic | 82 | 49 | $2,063 |
| Doxycycline Hyclate | Generic | 73 | 34 | $3,056 |
| Doxepin Hcl | Generic | 48 | 0 | $931 |
| Fluorouracil | Generic | 47 | 44 | $5,535 |
| Dupixent Pen (Dupilumab) | Brand | 42 | 0 | $160,853 |
| Prednisone | Generic | 41 | 18 | $305 |
| Methotrexate (Methotrexate Sodium) | Brand | 39 | 0 | $1,545 |
| Fluconazole | Generic | 31 | 18 | $227 |
Frequently asked questions
What is Dr. Cassandra Digby's medical specialty?
Dr. Cassandra Digby practices Nurse Practitioner in Fort Payne, AL.
Where does Dr. Cassandra Digby practice?
Dr. Cassandra Digby practices at 212 Airport RD W, Fort Payne, AL 359683347. Office phone: 2569791250.
What is Dr. Cassandra Digby's NPI?
Dr. Cassandra Digby's National Provider Identifier (NPI) is 1164817607, issued by NPPES.
Does Dr. Cassandra Digby accept Medicare assignment?
Dr. Cassandra Digby does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Cassandra Digby commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.